ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04111	Cell cycle - yeast	25/174	90/7206	1.98156715531e-20
ko04110	Cell cycle	30/174	145/7206	2.44925415247e-20
ko04113	Meiosis - yeast	16/174	70/7206	5.34214342492e-12
ko03440	Homologous recombination	12/174	41/7206	1.15545842582e-10
ko03030	DNA replication	11/174	38/7206	8.10930549259e-10
ko03460	Fanconi anemia pathway	10/174	51/7206	2.82447516623e-07
ko05206	MicroRNAs in cancer	16/174	177/7206	5.0205532016e-06
ko03410	Base excision repair	7/174	38/7206	2.84492541554e-05
ko03040	Spliceosome	13/174	145/7206	4.37223551187e-05
ko03008	Ribosome biogenesis in eukaryotes	9/174	79/7206	0.000109265476374
ko03430	Mismatch repair	5/174	22/7206	0.00014619780162
ko00240	Pyrimidine metabolism	10/174	110/7206	0.000303380042912
ko05166	HTLV-I infection	17/174	292/7206	0.000651991079382
ko03420	Nucleotide excision repair	6/174	46/7206	0.000764010686402
ko00310	Lysine degradation	7/174	73/7206	0.00180699883749
ko04330	Notch signaling pathway	6/174	62/7206	0.00364904453319
ko04151	PI3K-Akt signaling pathway	2/174	390/7206	0.00610620880607
ko04218	Cellular senescence	10/174	177/7206	0.0104061261661
ko03018	RNA degradation	6/174	84/7206	0.015642552282
ko05220	Chronic myeloid leukemia	6/174	85/7206	0.0165040403833
ko03013	RNA transport	9/174	166/7206	0.0188520236018
ko05223	Non-small cell lung cancer	5/174	66/7206	0.0211664018539
ko04020	Calcium signaling pathway	1/174	265/7206	0.0222526748604
ko05203	Viral carcinogenesis	13/174	277/7206	0.0244808536821
ko00270	Cysteine and methionine metabolism	4/174	47/7206	0.0261562886506
ko05219	Bladder cancer	4/174	48/7206	0.0280131075411
ko05214	Glioma	5/174	79/7206	0.0416829752026
ko03450	Non-homologous end-joining	2/174	15/7206	0.0495375056786
ko05212	Pancreatic cancer	5/174	83/7206	0.0497863915509